Skip to content
Zero Point Five Therapeutics, Inc.
  • Mission
  • Focus Areas
  • Pipeline
  • Designations
  • About
  • Contact
Learn More
← Back to home

Cookie Policy

Last updated: 2026-04-21

Placeholder — this page contains template language and has not been reviewed by counsel. Replace before launch.

What we use

This site uses very few cookies:

  • Cloudflare Turnstile — when you submit the contact form, Cloudflare may set short-lived cookies to verify that you are not a bot. These are essential for the form to function and are exempt from consent requirements under most privacy laws.
  • No analytics cookies. We use Cloudflare Web Analytics, which is cookieless.
  • No marketing or advertising cookies. We do not place tracking pixels or advertising tags.

Managing cookies

You can configure your browser to block cookies, though doing so may prevent the contact form from working.

Contact

Questions about cookies can be sent to contact@zeropointfivetherapeutics.com.

Zero Point Five Therapeutics, Inc.

Developing safe and efficacious treatments for neglected diseases.

Company
MissionFocus AreasPipelineDesignationsContact
Regulatory
Rare Pediatric Disease DesignationOrphan Drug DesignationClinicalTrials.gov
Contact
contact@zeropointfivetherapeutics.comzeropointfivetherapeutics.com
Forward-Looking Statements

This website contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the clinical development, regulatory strategy, and potential commercialization of Zero Point Five Therapeutics, Inc.'s product candidates. These statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected, including risks related to clinical trial outcomes, regulatory review and approval, manufacturing, competition, and market conditions. Forward-looking statements speak only as of the date on which they are made, and Zero Point Five Therapeutics, Inc. undertakes no obligation to update or revise any forward-looking statement, except as required by law.

Regulatory & Clinical Disclaimer

Zero Point Five Therapeutics, Inc.'s lead product candidate is an investigational drug that has not been approved by the U.S. Food and Drug Administration (FDA) or any other regulatory authority for any indication. The safety and efficacy of this investigational compound have not been established. Rare Pediatric Disease Designation and Orphan Drug Designation are granted by the FDA and are not a guarantee of regulatory approval. These designations provide certain development incentives but do not confirm that the product candidate will receive marketing approval or be commercially successful. Information on this website is intended for informational purposes only and does not constitute medical advice, a solicitation for investment, or an offer to sell securities.

No Offer of Securities

Nothing on this website constitutes an offer to sell, or a solicitation of an offer to buy, any securities of Zero Point Five Therapeutics, Inc. Any offering of securities will be made only pursuant to a formal offering memorandum or other applicable disclosure document in compliance with applicable federal and state securities laws.

© 2026 Zero Point Five Therapeutics, Inc. · All Rights Reserved
Privacy Policy·Terms of Use·Cookie Policy